Global Glutathione Market Overview:
Glutathione is the master antioxidant in the body and is heavily concentrated in tissues such as the liver, spleen and heart. Therefore, it plays a crucial role in immune function, detoxification capacity and protection against oxidative stress. The increasing glutathione levels can help prevent and/or mitigate the progression of diseases such as aging & related disorders, Alzheimer’s disease, chronic liver disease, diabetes, hypertension, cognitive impairment, and other clinical conditions.
As per latest study released by AMA Research, the Global Glutathione market is expected to see growth rate of 7.4%Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Historical Period | 2018-2023 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Shifting Consumer Purchasing Trends For Herbal And Organic Cosmetics Products
Market Growth Drivers:
Growing Use of Oxidized Glutathione (GSH) in Treatment of Cancer Patients and Increasing Demand for Preventing Skin Aging Problems
Challenges:
Maintaining the level of GSH else it may lead to Stomach Bloating and Cramping Problems
Restraints:
High Cost of Glutathione Products and Side Effects of Using Glutathione Supplements
Opportunities:
Increasing Research on Glutathione Metabolism and Adoption of Glutathione to Maintains the Activity of Vitamins C and E
Competitive Landscape:
The rising number of players expected to enter the global market is predicted to enhance the competition level as well as encourage the growth of the overall market shortly. Players are anticipated to focus on the development of new compounds, which is likely to encourage the growth of the global market throughout the forecast period.
Some of the key players profiled in the report are Cayman Chemical Company (United States), Kyowa Hakko Bio Co. Ltd. (Japan), Nissor Pharmaceuticals Ltd. (India), Shandong Jincheng Biological Pharmaceutical Co. Ltd. (China), KOHJIN Life Sciences Co. Ltd. (Japan), Shenzhen GSH Bio-Technology Co., Ltd. (China), Kaiping Genuine Biochemical Pharmaceutical Co. Ltd (China), Herbo Nutra (India), Haihang IndustryCo. Ltd. (China), Meteoric Biopharmaceuticals Pvt. Ltd. (India), Xi'an Fengzu Biological Technology Co. Ltd (China), YaoPharma Co., Ltd. (China) and Brandon Products Ltd. (Italy). Analyst at AMA Research see China and India Vendors to retain maximum share of Global Glutathione market by 2030. Considering Market by Vitamin, the sub-segment i.e. Vitamin B will boost the Glutathione market. Considering Market by Sales Channel, the sub-segment i.e. Online will boost the Glutathione market.
Latest Market Insights:
In December 2021, Nippon Fine Chemical Co., Ltd. announced the acquisition of Tokyo Chemical Industry Co., Ltd.'s pharmaceutical and fine chemicals business, including its glutathione production capabilities.
On October 10, 2022, Lonza and Medicago Inc. announced a partnership to develop and manufacture a glutathione-based adjuvant for Medicago's COVID-19 vaccine candidate.
What Can be Explored with the Glutathione Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Glutathione Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Glutathione
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Glutathione market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Glutathione market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Glutathione Manufacturer, Raw Material Suppliers, Dealers, Suppliers, Traders, and Distributors, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End User Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.